Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.34 EUR | 0.00% |
|
0.00% | 0.00% |
02:07pm | BBVA : Jefferies reiterates its Buy rating | ZD |
21/06 | European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher | MT |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Its low valuation, with P/E ratio at 6.12 and 6.16 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
0.00% | 5.66TCr | - | ||
+15.40% | 56TCr | C+ | ||
+17.29% | 31TCr | C+ | ||
+19.37% | 25TCr | C+ | ||
+24.30% | 19TCr | B- | ||
+28.86% | 17TCr | B- | ||
+8.94% | 16TCr | C+ | ||
-2.16% | 15TCr | B- | ||
+5.99% | 15TCr | B- | ||
+13.42% | 14TCr | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BBVA Stock
- BVA Stock
- Ratings Banco Bilbao Vizcaya Argentaria